Cencora, Inc. (NYSE:COR) Shares Purchased by Tidal Investments LLC

Tidal Investments LLC lifted its position in shares of Cencora, Inc. (NYSE:COR - Free Report) by 18.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 20,684 shares of the company's stock after buying an additional 3,189 shares during the period. Tidal Investments LLC's holdings in Cencora were worth $4,656,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Dynamic Advisor Solutions LLC boosted its stake in Cencora by 9.4% in the 2nd quarter. Dynamic Advisor Solutions LLC now owns 1,012 shares of the company's stock worth $228,000 after buying an additional 87 shares during the last quarter. ORG Partners LLC purchased a new stake in Cencora during the second quarter valued at about $81,000. Blue Trust Inc. increased its stake in Cencora by 58.5% during the second quarter. Blue Trust Inc. now owns 1,330 shares of the company's stock worth $323,000 after acquiring an additional 491 shares during the last quarter. Vista Investment Partners LLC raised its holdings in shares of Cencora by 1.0% in the 2nd quarter. Vista Investment Partners LLC now owns 19,393 shares of the company's stock worth $4,369,000 after purchasing an additional 195 shares during the period. Finally, Vaughan Nelson Investment Management L.P. lifted its stake in shares of Cencora by 185.5% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 131,873 shares of the company's stock valued at $29,710,000 after purchasing an additional 85,680 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company's stock.

Analyst Ratings Changes

COR has been the subject of a number of research analyst reports. Mizuho assumed coverage on shares of Cencora in a research report on Wednesday, December 4th. They set an "outperform" rating and a $280.00 target price for the company. Leerink Partners decreased their price objective on shares of Cencora from $277.00 to $275.00 and set an "outperform" rating for the company in a research note on Monday, October 7th. Robert W. Baird raised their target price on shares of Cencora from $287.00 to $292.00 and gave the company an "outperform" rating in a research note on Thursday, November 7th. StockNews.com cut shares of Cencora from a "strong-buy" rating to a "buy" rating in a research report on Friday, September 20th. Finally, Barclays raised their price objective on Cencora from $263.00 to $290.00 and gave the company an "overweight" rating in a research report on Thursday, November 7th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Cencora presently has an average rating of "Moderate Buy" and a consensus target price of $275.60.

Cencora Stock Up 0.1 %

Shares of NYSE COR traded up $0.12 during midday trading on Friday, reaching $232.24. 780,788 shares of the company's stock were exchanged, compared to its average volume of 1,386,901. The business's fifty day moving average price is $238.36 and its two-hundred day moving average price is $233.91. Cencora, Inc. has a 52-week low of $195.83 and a 52-week high of $253.27. The stock has a market capitalization of $44.89 billion, a PE ratio of 30.92, a price-to-earnings-growth ratio of 1.54 and a beta of 0.45. The company has a debt-to-equity ratio of 4.84, a quick ratio of 0.53 and a current ratio of 0.88.

Cencora Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date was Friday, November 15th. This is a positive change from Cencora's previous quarterly dividend of $0.51. Cencora's dividend payout ratio is 29.29%.

Insider Transactions at Cencora

In other news, Chairman Steven H. Collis sold 21,509 shares of the business's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $235.80, for a total value of $5,071,822.20. Following the completion of the sale, the chairman now directly owns 285,088 shares in the company, valued at approximately $67,223,750.40. The trade was a 7.02 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last 90 days, insiders have sold 93,018 shares of company stock valued at $22,478,942. Insiders own 15.80% of the company's stock.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.